Kamada (KMDA) Non-Current Deferred Tax Liability (2018 - 2026)

Kamada (KMDA) posted quarterly Non-Current Deferred Tax Liability of $2.9 million for Q1 2026, up 39.06% year-on-year from $2.1 million in Q1 2025, and up 73.59% on a QoQ basis from $1.7 million in Q4 2025.

Kamada (KMDA) Non-Current Deferred Tax Liability (2018 - 2026) Analysis & Trends

Kamada (KMDA) has reported Non-Current Deferred Tax Liability for 6 consecutive years, with $2.9 million the latest figure, recorded in Q1 2026.

  • Quarterly Non-Current Deferred Tax Liability rose 39.06% year-over-year to $2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.9 million (up 39.06% YoY) and the FY2025 annual result came in at $1.7 million, up 238.32% from the prior year.
  • Non-Current Deferred Tax Liability grew to $2.9 million in Q1 2026 per KMDA's latest filing, from $1.7 million in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for KMDA reached as high as $2.9 million in Q1 2026 and fell as low as $488000.0 in Q4 2024.
  • A 3-year average of $1.6 million and a median of $1.7 million in 2025 frame the typical range for Non-Current Deferred Tax Liability.
  • Annual changes were most pronounced in 2025 — Non-Current Deferred Tax Liability surged 238.32% — and 2026, when it surged 39.06%.
  • Year by year, Non-Current Deferred Tax Liability stood at $488000.0 in 2024, then jumped by 238.32% to $1.7 million in 2025, then jumped by 73.59% to $2.9 million in 2026.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $2.9 million, $1.7 million, and $1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Kamada 401.22 Mn 328.07 Mn 19.12 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.87 Mn
Mar 31, 2026 2.87 Mn
Dec 31, 2025 1.65 Mn
Dec 31, 2025 1.65 Mn
Sep 30, 2025 1.72 Mn
Sep 30, 2025 1.72 Mn
Jun 30, 2025 659,000.00
Jun 30, 2025 659,000.00
Mar 31, 2025 2.06 Mn
Mar 31, 2025 2.06 Mn
Dec 31, 2024 488,000.00
Dec 31, 2024 488,000.00
Sep 30, 2020 298,000.00
Sep 30, 2020 298,000.00
Jun 30, 2020 632,000.00
Jun 30, 2020 632,000.00
Mar 31, 2020 939,000.00
Mar 31, 2020 939,000.00
Dec 31, 2019 1.31 Mn
Dec 31, 2019 1.31 Mn